Fitzgerald Kevin Joseph
CIK 0001886431
CSO & EVP, Head of ResearchDirector
Filings
22
Latest Apr 9, 2026
Issuers covered
2
Showing
22 of 22
Page 1
Track record
152 of 152 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 152 | 64% | +3.1% | +1.3% | +16.6% | -9.6% |
| 90 days | 152 | 57% | +0.7% | +5.4% | +27.8% | -26.0% |
| 180 days | 97 | 32% | -23.3% | -1.4% | +37.8% | -84.1% |
| 365 days | 66 | 0% | -40.5% | -33.1% | -29.7% | -77.8% |
Issuers
Companies where Fitzgerald Kevin Joseph has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals, Inc. | 15 | Mar 6, 2026 |
| OVID | Ovid Therapeutics Inc. | 7 | Apr 9, 2026 |
All filings
22 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|